Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Therapeutic response shortened? 114 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Therapeutic response shortened have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.2% of all adverse event reports for ARIPIPRAZOLE.

114
Reports of Therapeutic response shortened with ARIPIPRAZOLE
0.2%
of all ARIPIPRAZOLE reports
0
Deaths
18
Hospitalizations

How Dangerous Is Therapeutic response shortened From ARIPIPRAZOLE?

Of the 114 reports, 18 (15.8%) required hospitalization.

Is Therapeutic response shortened Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 114 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Therapeutic response shortened?

DUPILUMAB (6,720) ADALIMUMAB (2,597) INFLIXIMAB-DYYB (1,837) INFLIXIMAB (1,231) SECUKINUMAB (1,097) RISANKIZUMAB-RZAA (1,089) CARBIDOPA\LEVODOPA (1,027) ONABOTULINUMTOXINA (907) ERENUMAB-AOOE (805) CERTOLIZUMAB PEGOL (687)

Which ARIPIPRAZOLE Alternatives Have Lower Therapeutic response shortened Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Therapeutic response shortened Reports All Drugs Causing Therapeutic response shortened ARIPIPRAZOLE Demographics